Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Vaccines(10), H. 5 - ISSN 2076-393X
In: MDPI AG, Basel
- Ereignis
-
Veröffentlichung
- (wo)
-
Kiel
- (wer)
-
Universitätsbibliothek Kiel
- (wann)
-
2022
- Urheber
-
Markewitz, Robert
Juhl, David
Pauli, Daniela
Görg, Siegfried
Junker, Ralf Heinrich
Rupp, Jan
Engel, Sarah
Steinhagen, Katja
Herbst, Victor
Zapf, Dorinja
Krüger, Christina
Brockmann, Christian
Leypoldt, Frank
Dargvainiene, Justina
Schomburg, Benjamin
Sharifzadeh, Shahpour Reza
Salek Nejad, Lukas
Wandinger, Klaus-Peter
Ziemann, Malte
- URN
-
urn:nbn:de:gbv:8:3-2024-00173-8
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Markewitz, Robert
- Juhl, David
- Pauli, Daniela
- Görg, Siegfried
- Junker, Ralf Heinrich
- Rupp, Jan
- Engel, Sarah
- Steinhagen, Katja
- Herbst, Victor
- Zapf, Dorinja
- Krüger, Christina
- Brockmann, Christian
- Leypoldt, Frank
- Dargvainiene, Justina
- Schomburg, Benjamin
- Sharifzadeh, Shahpour Reza
- Salek Nejad, Lukas
- Wandinger, Klaus-Peter
- Ziemann, Malte
- Universitätsbibliothek Kiel
Entstanden
- 2022
Ähnliche Objekte (12)
Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort study
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
Humoral immune response after different SARS-CoV-2 vaccination regimens
Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade
Impact of Foxp3+ regulatory T cells on the immunogenicity of tuberculosis vaccination
Low immunogenicity of malaria pre‐erythrocytic stages can be overcome by vaccination
Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV
Cross-reactive cellular and humoral immunity in heterologous SARS-CoV-2 vaccination
Heterologous vaccination against human tuberculosis modulates antigen‐specific CD 4 + T ‐cell function
Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort study
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
Humoral immune response after different SARS-CoV-2 vaccination regimens
Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade
Impact of Foxp3+ regulatory T cells on the immunogenicity of tuberculosis vaccination
Low immunogenicity of malaria pre‐erythrocytic stages can be overcome by vaccination
Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV
Cross-reactive cellular and humoral immunity in heterologous SARS-CoV-2 vaccination
Heterologous vaccination against human tuberculosis modulates antigen‐specific CD 4 + T ‐cell function
Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort study
Optimization of heterologous DNA-prime, protein boost regimens and site of vaccination to enhance therapeutic immunity against human papillomavirus-associated disease
Immunogenicity evaluation after BNT162b2 booster vaccination in healthcare workers
Humoral immune response after different SARS-CoV-2 vaccination regimens
Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade
Impact of Foxp3+ regulatory T cells on the immunogenicity of tuberculosis vaccination
Low immunogenicity of malaria pre‐erythrocytic stages can be overcome by vaccination
Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV
Cross-reactive cellular and humoral immunity in heterologous SARS-CoV-2 vaccination